» Articles » PMID: 35819567

Multifocal Fibrosing Thyroiditis: an Under-recognized Mimicker of Papillary Thyroid Carcinoma

Overview
Journal Endocr Pathol
Specialties Endocrinology
Pathology
Date 2022 Jul 12
PMID 35819567
Authors
Affiliations
Soon will be listed here.
Abstract

Multifocal fibrosing thyroiditis (MFT) is an enigmatic entity, characterized by multiple fibrotic scar-like lesions with a paucicellular fibrotic center surrounded by a cellular peripheral area with reactive-appearing follicular cell atypia and variable chronic inflammation. Although poorly recognized and likely underreported in surgical pathology, the entity is considered rare with only 65 cases to date-including the current one reported to expand on the preoperative findings of this under-recognized entity. The average age of the patients is 46.8 years (range 15-71 years), 94% are female, with female to male ratio of 15:1. Individual MFT lesions typically have a superficial location. The average number of fibrotic lesions is 15.4 (range 2-51 per MFT case). Their average size is 3.1 mm (range 0.4-15.1). MFT is a disorder of diseased thyroids, typically found postoperatively in glands removed for other reasons, such as chronic lymphocytic/Hashimoto thyroiditis (32.3%), follicular nodular disease (nodular hyperplasia) (30.1%), hyperthyroidism/diffuse hyperplasia (Graves disease) (9.2%). Intriguing is the association with papillary thyroid carcinoma-present in 38.5% of MFT cases, and particularly with sub-centimetric and multifocal papillary thyroid carcinoma, with which MFT can be confused. Cases where MFT is the only thyroid pathology (7.7%) can be preoperatively mistaken for papillary thyroid carcinoma, due to worrisome ultrasound (US) and cytologic features, both of which are here documented for the first time as a component of this article. Wider recognition of MFT and of its cytologic and ultrasound features at preoperative evaluation may reduce unnecessary thyroidectomies.

Citing Articles

Clinical value of ultrasound parameters PI, TTP, and MTT in assessing cervical lymph node metastasis of papillary thyroid carcinoma.

Kong Q, Yu Y, Qian Q, Sun H Am J Transl Res. 2024; 16(3):809-816.

PMID: 38586094 PMC: 10994806. DOI: 10.62347/QWDR4613.

References
1.
Kholova I, Kalfert D, Lintusaari J, Rajakorpi E, Ludvikova M . Follicular Epithelial Dysplasia as Hashimoto Thyroiditis-Related Atypia: a Series of 91 Specimens. Endocr Pathol. 2021; 32(3):368-374. PMC: 8370905. DOI: 10.1007/s12022-021-09679-w. View

2.
HAZARD J . Small papillary carcinoma of the thyroid. A study with special reference to so-called nonencapsulated sclerosing tumor. Lab Invest. 1960; 9:86-97. View

3.
Canberk S . Precursor and borderline lesions of the thyroid (indolent lesions of epithelial origin): from theory to practice. Gland Surg. 2020; 9(5):1724-1734. PMC: 7667122. DOI: 10.21037/gs-20-429. View

4.
Trimboli P, Fulciniti F, Paone G, Barizzi J, Piccardo A, Merlo E . Risk of Malignancy (ROM) of Thyroid FNA Diagnosed as Suspicious for Malignancy or Malignant: an Institutional Experience with Systematic Review and Meta-Analysis of Literature. Endocr Pathol. 2020; 31(1):52-56. DOI: 10.1007/s12022-019-09602-4. View

5.
Acquaviva G, Visani M, Repaci A, Rhoden K, de Biase D, Pession A . Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance. Histopathology. 2017; 72(1):6-31. DOI: 10.1111/his.13380. View